Scintigraphy with [<sup>111</sup>In]Octreotide and <sup>201</sup>Tl in a Hürthle Cell Thyroid Carcinoma without Detectable Radio-Iodine Uptake

Papillary and Follicular Thyroid Carcinoma

1998 • 1,632 citations

Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.

1996 • 474 citations

Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan.

1995 • 320 citations

[18F]-2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography Localizes Residual Thyroid Cancer in Patients with Negative Diagnostic 131I Whole Body Scans and Elevated Serum Thyroglobulin Levels

1999 • 314 citations

Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels.

1987 • 251 citations

Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan

1995 • 160 citations

Redifferentiation Therapy with Retinoids: Therapeutic Option for Advanced Follicular and Papillary Thyroid Carcinoma

1998 • 139 citations

Radionuclide diagnosis and therapy of thyroid cancer: Current status report

1985 • 124 citations

Somatostatin Receptor Subtype Expression in Human Thyroid and Thyroid Carcinoma Cell Lines1

1997 • 118 citations

[18F]-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Localizes Residual Thyroid Cancer in Patients with Negative Diagnostic 131I Whole Body Scans and Elevated Serum Thyroglobulin Levels

1999 • 109 citations

Imaging of Locally Recurrent and Metastatic Thyroid Cancer with Positron Emission Tomography

1999 • 96 citations

111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors.

2000 • 91 citations

Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan.

1996 • 80 citations

Radiolabeled peptides in diagnosis and tumor imaging: Clinical overview

2002 • 69 citations

Positron emission tomography with F-18-deoxyglucose in patients with differentiated thyroid carcinoma, elevated thyroglobulin levels, and negative iodine scans

1998 • 68 citations

Redifferentiation therapy with retinoic acid in follicular thyroid cancer.

1998 • 64 citations

Somatostatin Receptor Subtype Expression in Human Thyroid and Thyroid Carcinoma Cell Lines

1997 • 54 citations

Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan

1996 • 49 citations

Evaluation of suspected recurrent papillary thyroid carcinoma with [18F]fluorodeoxyglucose positron emission tomography

1998 • 48 citations

Evaluation of Indium-111 Pentetreotide Somatostatin Receptor Scintigraphy to Detect Recurrent Thyroid Carcinoma in Patients with Negative Radioiodine Scintigraphy

1999 • 36 citations

Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake

1998 • 36 citations

The Use of Imaging Studies in the Diagnosis and Management of Thyroid Cancer and Hyperparathyroidism

1999 • 34 citations

Somatostatin receptor expression in Hürthle cell cancer of the thyroid.

1998 • 33 citations

Relative value of thallium-201 and iodine-131 scans in the detection of recurrence or distant metastasis of well differentiated thyroid carcinoma

1998 • 26 citations

Expression of somatostatin receptors in oncocytic (Hürthle cell) neoplasia of the thyroid

1999 • 21 citations

Technetium-99m-furifosmin in the follow-up of differentiated thyroid carcinoma.

1998 • 15 citations

Thallium-201 uptake with negative iodine-131 scintigraphy and serum thyroglobulin in metastatic oxyphilic papillary thyroid carcinoma.

1998 • 14 citations

The relevance of somatostatin receptors in thyroid neoplasia.

1998 • 14 citations

First Report of Hürthle Cell Carcinoma Revealed by Octreotide Scanning

1998 • 12 citations

[Somatostatin receptor status in non-medullary thyroid carcinoma].

1999 • 6 citations

Guidelines for the Use of Radio-iodine, Thyroid Hormone, and Treatment of Metastatic Disease in Patients With Differentiated Thyroid Cancer

1998 • 5 citations

[Value of scintigraphic explorations by radiomarkers others than iodine radioisotope in differentiated thyroid cancer].

1997 • 2 citations